Dashboard
Financial statements
DHR

Company financials

Danaher Corporation

Health Care Life Sciences Tools & Services Washington, D.C. Last filing Feb 24, 2026 · FY2025
Revenue FY2025
$24.6B
3y CAGR -2.7% P10
Net income FY2025
$3.6B
Net margin +14.7% P63
Total assets FY2025
$83.5B
ROA +4.3% P36
Operating cash flow FY2025
$6.4B
FCF margin +21.4% P75
19 yrs · FY2007–FY2025 8 filed · 1 derived · 0 blank

Balance Sheet

Assets, liabilities, and equity

24 accounts · 1 year
Total assets $83.5B
Total liabilities ~$30.9B
Shareholders equity $52.5B
Account 2025 Trend
Assets
Cash and Cash Equivalents $4.6B
Accounts Receivable $3.9B
Inventory $2.5B
Prepaid Expenses $1.7B
Total Current Assets $12.8B
Property,Plant and Equipment $5.5B
Goodwill $43.2B
Intangible Assets $17.8B
Other Noncurrent Assets $4.2B
Total Assets $83.5B
Liabilities
Accounts Payable $1.8B
Accrued Liabilities $5.0B
Current Portion of Long Term Debt $2.0M
Total Current Liabilities $6.8B
Long Term Debt $18.4B
Other Noncurrent Liabilities $5.7B
Equity
Common Stock $9.0M
Additional Paid In Capital $17.2B
Retained Earnings $46.9B
Treasury Stock $11.4B
Accumulated Other Comprehensive Income $-207.0M
Total Stockholders Equity $52.5B
Noncontrolling Interest $7.0M
Total Liabilitiesand Equity $83.5B

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year
Ratio 2025
Profitability
Gross margin +59.1%
Operating margin +19.1%
Net margin +14.7%
FCF margin +21.4%
Growth
Revenue CAGR (3y) -2.7%
Returns
ROE +6.9%
ROA +4.3%
ROIC +6.0%
Liquidity
Current ratio 1.87x
Quick ratio 1.25x
Leverage
D/E 0.59x
Interest coverage 17.70x
Efficiency
Asset turnover 0.29x
Cash conversion cycle +82d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds DHR to your watchlist.